rs4747202
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002778.4(PSAP):c.1540-34C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.112 in 1,610,128 control chromosomes in the GnomAD database, including 13,892 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.14 ( 1857 hom., cov: 33)
Exomes 𝑓: 0.11 ( 12035 hom. )
Consequence
PSAP
NM_002778.4 intron
NM_002778.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0710
Publications
7 publications found
Genes affected
PSAP (HGNC:9498): (prosaposin) This gene encodes a highly conserved preproprotein that is proteolytically processed to generate four main cleavage products including saposins A, B, C, and D. Each domain of the precursor protein is approximately 80 amino acid residues long with nearly identical placement of cysteine residues and glycosylation sites. Saposins A-D localize primarily to the lysosomal compartment where they facilitate the catabolism of glycosphingolipids with short oligosaccharide groups. The precursor protein exists both as a secretory protein and as an integral membrane protein and has neurotrophic activities. Mutations in this gene have been associated with Gaucher disease and metachromatic leukodystrophy. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
PSAP Gene-Disease associations (from GenCC):
- combined PSAP deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
- Gaucher disease due to saposin C deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- Krabbe disease due to saposin A deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, G2P
- metachromatic leukodystrophy due to saposin B deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- Parkinson disease 24, autosomal dominant, susceptibility toInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 10-71817510-G-A is Benign according to our data. Variant chr10-71817510-G-A is described in ClinVar as Benign. ClinVar VariationId is 258811.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.353 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PSAP | NM_002778.4 | c.1540-34C>T | intron_variant | Intron 13 of 13 | ENST00000394936.8 | NP_002769.1 | ||
| PSAP | NM_001042465.3 | c.1549-34C>T | intron_variant | Intron 14 of 14 | NP_001035930.1 | |||
| PSAP | NM_001042466.3 | c.1546-34C>T | intron_variant | Intron 14 of 14 | NP_001035931.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.140 AC: 21256AN: 151992Hom.: 1848 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
21256
AN:
151992
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.154 AC: 38517AN: 250870 AF XY: 0.141 show subpopulations
GnomAD2 exomes
AF:
AC:
38517
AN:
250870
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.110 AC: 159703AN: 1458018Hom.: 12035 Cov.: 29 AF XY: 0.108 AC XY: 78030AN XY: 725608 show subpopulations
GnomAD4 exome
AF:
AC:
159703
AN:
1458018
Hom.:
Cov.:
29
AF XY:
AC XY:
78030
AN XY:
725608
show subpopulations
African (AFR)
AF:
AC:
6563
AN:
33364
American (AMR)
AF:
AC:
13615
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
1746
AN:
26116
East Asian (EAS)
AF:
AC:
15435
AN:
39678
South Asian (SAS)
AF:
AC:
9783
AN:
86176
European-Finnish (FIN)
AF:
AC:
6921
AN:
53338
Middle Eastern (MID)
AF:
AC:
329
AN:
5686
European-Non Finnish (NFE)
AF:
AC:
98035
AN:
1108680
Other (OTH)
AF:
AC:
7276
AN:
60258
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
6371
12742
19112
25483
31854
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4100
8200
12300
16400
20500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.140 AC: 21280AN: 152110Hom.: 1857 Cov.: 33 AF XY: 0.143 AC XY: 10643AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
21280
AN:
152110
Hom.:
Cov.:
33
AF XY:
AC XY:
10643
AN XY:
74382
show subpopulations
African (AFR)
AF:
AC:
8027
AN:
41494
American (AMR)
AF:
AC:
2879
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
218
AN:
3468
East Asian (EAS)
AF:
AC:
1895
AN:
5172
South Asian (SAS)
AF:
AC:
616
AN:
4818
European-Finnish (FIN)
AF:
AC:
1349
AN:
10594
Middle Eastern (MID)
AF:
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5903
AN:
67974
Other (OTH)
AF:
AC:
261
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
892
1784
2677
3569
4461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
867
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Combined PSAP deficiency Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Krabbe disease due to saposin A deficiency Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sphingolipid activator protein 1 deficiency Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.